Cargando…
Differentiating peripheral cholangiocarcinoma in stages T1N0M0 and T2N0M0 from hepatic hypovascular nodules using dynamic contrast-enhanced MRI
Because cholangiocarcinoma shows no specific clinical signs or symptoms and presents with non-specific biological and tumor markers in the early stages, MRI findings often lack typical features before this lesion becomes symptomatic and might be mistaken for other liver lesions. An evaluation of rel...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5556016/ https://www.ncbi.nlm.nih.gov/pubmed/28808285 http://dx.doi.org/10.1038/s41598-017-08634-2 |
_version_ | 1783256985530007552 |
---|---|
author | Li, Shihong Qian, Haizhen Peng, Yu Jia, Huihui Lin, Guangwu |
author_facet | Li, Shihong Qian, Haizhen Peng, Yu Jia, Huihui Lin, Guangwu |
author_sort | Li, Shihong |
collection | PubMed |
description | Because cholangiocarcinoma shows no specific clinical signs or symptoms and presents with non-specific biological and tumor markers in the early stages, MRI findings often lack typical features before this lesion becomes symptomatic and might be mistaken for other liver lesions. An evaluation of relevant radiological findings in nodular cholangiocarcinoma (≤3 cm) in stages T1N0M0 and T2N0M0 is urgently needed. In our study, we compared two groups of liver hypovascular nodules and found that a distinct margin and enhanced area/nodule size >2/3 in the delayed phase were more frequently observed in cholangiocarcinoma cases than in metastatic nodule cases in which markedly high signal intensity on T2WI was common (p < 0.05). The results also revealed that in the both the portal and delayed phases, an enhanced area/nodule size >2/3 favored cholangiocarcinoma, whereas the presence of regional markedly higher SI on T2WI favored benign nodules. Furthermore, signs of peripheral washout in the delayed phase only appeared in cholangiocarcinoma cases. |
format | Online Article Text |
id | pubmed-5556016 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-55560162017-08-16 Differentiating peripheral cholangiocarcinoma in stages T1N0M0 and T2N0M0 from hepatic hypovascular nodules using dynamic contrast-enhanced MRI Li, Shihong Qian, Haizhen Peng, Yu Jia, Huihui Lin, Guangwu Sci Rep Article Because cholangiocarcinoma shows no specific clinical signs or symptoms and presents with non-specific biological and tumor markers in the early stages, MRI findings often lack typical features before this lesion becomes symptomatic and might be mistaken for other liver lesions. An evaluation of relevant radiological findings in nodular cholangiocarcinoma (≤3 cm) in stages T1N0M0 and T2N0M0 is urgently needed. In our study, we compared two groups of liver hypovascular nodules and found that a distinct margin and enhanced area/nodule size >2/3 in the delayed phase were more frequently observed in cholangiocarcinoma cases than in metastatic nodule cases in which markedly high signal intensity on T2WI was common (p < 0.05). The results also revealed that in the both the portal and delayed phases, an enhanced area/nodule size >2/3 favored cholangiocarcinoma, whereas the presence of regional markedly higher SI on T2WI favored benign nodules. Furthermore, signs of peripheral washout in the delayed phase only appeared in cholangiocarcinoma cases. Nature Publishing Group UK 2017-08-14 /pmc/articles/PMC5556016/ /pubmed/28808285 http://dx.doi.org/10.1038/s41598-017-08634-2 Text en © The Author(s) 2017 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Li, Shihong Qian, Haizhen Peng, Yu Jia, Huihui Lin, Guangwu Differentiating peripheral cholangiocarcinoma in stages T1N0M0 and T2N0M0 from hepatic hypovascular nodules using dynamic contrast-enhanced MRI |
title | Differentiating peripheral cholangiocarcinoma in stages T1N0M0 and T2N0M0 from hepatic hypovascular nodules using dynamic contrast-enhanced MRI |
title_full | Differentiating peripheral cholangiocarcinoma in stages T1N0M0 and T2N0M0 from hepatic hypovascular nodules using dynamic contrast-enhanced MRI |
title_fullStr | Differentiating peripheral cholangiocarcinoma in stages T1N0M0 and T2N0M0 from hepatic hypovascular nodules using dynamic contrast-enhanced MRI |
title_full_unstemmed | Differentiating peripheral cholangiocarcinoma in stages T1N0M0 and T2N0M0 from hepatic hypovascular nodules using dynamic contrast-enhanced MRI |
title_short | Differentiating peripheral cholangiocarcinoma in stages T1N0M0 and T2N0M0 from hepatic hypovascular nodules using dynamic contrast-enhanced MRI |
title_sort | differentiating peripheral cholangiocarcinoma in stages t1n0m0 and t2n0m0 from hepatic hypovascular nodules using dynamic contrast-enhanced mri |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5556016/ https://www.ncbi.nlm.nih.gov/pubmed/28808285 http://dx.doi.org/10.1038/s41598-017-08634-2 |
work_keys_str_mv | AT lishihong differentiatingperipheralcholangiocarcinomainstagest1n0m0andt2n0m0fromhepatichypovascularnodulesusingdynamiccontrastenhancedmri AT qianhaizhen differentiatingperipheralcholangiocarcinomainstagest1n0m0andt2n0m0fromhepatichypovascularnodulesusingdynamiccontrastenhancedmri AT pengyu differentiatingperipheralcholangiocarcinomainstagest1n0m0andt2n0m0fromhepatichypovascularnodulesusingdynamiccontrastenhancedmri AT jiahuihui differentiatingperipheralcholangiocarcinomainstagest1n0m0andt2n0m0fromhepatichypovascularnodulesusingdynamiccontrastenhancedmri AT linguangwu differentiatingperipheralcholangiocarcinomainstagest1n0m0andt2n0m0fromhepatichypovascularnodulesusingdynamiccontrastenhancedmri |